Simulations Plus Announces Third Quarter Fiscal Year 2024 Earnings and Conference Call Date

6/18/24 8:30:00 AM ET

EDP Services

Technology

Get the next $SLP alert in real time by email

Conference call to be on Tuesday, July 2, 2024, at 5 p.m. EDT

Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus"), announced today that it will report third quarter fiscal 2024 financial results after the market close on Tuesday, July 2, 2024.

Management will host a conference call that same day at 5:00 p.m. Eastern Time to discuss the results. Investment professionals and all current and prospective shareholders are invited to join the live webcast by registering here. The conference call can also be accessed by dialing 1-877-451-6152 (domestic) or 1-201-389-0879 (international) or by clicking on this Call me™ link to request a return call. The webcast can be accessed on the investor relations page of the Simulations Plus website at www.simulations-plus.com/investorscorporate-profile/corporate-profile/ where it will also be available for replay approximately one hour following the call.

About Simulations Plus

With more than 25 years of experience serving clients globally, Simulations Plus stands as a premier provider in the Biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. Our comprehensive biosimulation solutions integrate artificial intelligence/machine learning (AI/ML), physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. We also deliver simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Our cutting-edge technology is licensed and utilized by leading pharmaceutical, biotechnology, and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com. Follow us on LinkedIn | X | YouTube.

Environmental, Social, and Governance (ESG)

We focus our Environmental, Social, and Governance (ESG) efforts where we can have the most positive impact. To learn more about our latest initiatives and priorities, please visit our website to read our 2023 ESG update.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240618346263/en/

Get the next $SLP alert in real time by email

Recent Analyst Ratings for

$SLP

Date	Price Target	Rating	Analyst
11/15/2024	$39.00	Overweight	Stephens
7/29/2024	$47.00	Overweight	KeyBanc Capital Markets
7/16/2024		Mkt Perform	JMP Securities
6/28/2024		Outperform	William Blair
5/9/2023	$55.00	Buy	BTIG Research
10/26/2021	$65.00 → $53.00	Hold → Buy	Craig Hallum
7/13/2021	$95.00 → $54.00	Outperform	Raymond James

More analyst ratings

Simulations Plus Announces Third Quarter Fiscal Year 2024 Earnings and Conference Call Date

Chat with this insight

Recent Analyst Ratings for $SLP

$SLP Press Releases

Fastest customizable press release news feed in the world

Simulations Plus to Participate in the BTIG Digital Health Forum

Simulations Plus and the University of Connecticut Receive New FDA Grant to Expand Mechanistic Modeling Approaches for Long-Acting Injectables

Simulations Plus to Participate in the Stephens Annual Investment Conference

$SLP Market Insights

Live Market Insights

JMP Securities Initiates Coverage On Simulations Plus with Market Perform Rating

Simulations Plus Announces New Research Project With The International Collaboration On Cosmetics Safety To Evaluate The Use Of Physiologically-Based Kinetic Modeling Approaches To Advance Animal-Free Science For Cosmetics And Other Non-Pharmaceutical Ingredients

Craig-Hallum Reiterates Buy on Simulations Plus, Maintains $56 Price Target

$SLP Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Paglia John Kenneth was granted 992 shares, increasing direct ownership by 23% to 5,278 units (SEC Form 4)

Director Weiner Daniel L was granted 992 shares, increasing direct ownership by 14% to 7,986 units (SEC Form 4)

Director Lavange Lisa was granted 992 shares, increasing direct ownership by 15% to 7,800 units (SEC Form 4)

$SLP Financials

Live finance-specific insights

Simulations Plus Reports Fourth Quarter and Fiscal 2024 Financial Results

Simulations Plus Announces Fourth Quarter and Fiscal Year 2024 Earnings and Conference Call Date

Simulations Plus Reports Third Quarter Fiscal 2024 Financial Results

$SLP SEC Filings

SEC Form 10-K filed by Simulations Plus Inc.

Simulations Plus Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

Simulations Plus Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

$SLP Large Ownership Changes

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13G/A filed by Simulations Plus Inc.

SEC Form SC 13G/A filed by Simulations Plus Inc. (Amendment)

SEC Form SC 13G/A filed by Simulations Plus Inc. (Amendment)

$SLP Leadership Updates

Live Leadership Updates

QHP Capital-Backed Pro-ficiency Acquired by Simulations Plus

Simulations Plus Names Industry Veteran Will Frederick as Chief Financial Officer

$SLP Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Stephens initiated coverage on Simulations Plus with a new price target

KeyBanc Capital Markets initiated coverage on Simulations Plus with a new price target

JMP Securities initiated coverage on Simulations Plus

Recent Analyst Ratings for
$SLP

$SLP
Press Releases

$SLP
Market Insights

$SLP
Insider Trading

$SLP
Financials

$SLP
SEC Filings

$SLP
Large Ownership Changes

$SLP
Leadership Updates

$SLP
Analyst Ratings